Weight change, weight cycling and mortality in the ERFORT Male Cohort Study.

Weight change, weight cycling and mortality in the ERFORT Male Cohort Study. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Weight change, weight cycling and mortality in the ERFORT Male Cohort Study. Abstract Text:

Peter Rzehak,Christa Meisinger,Gabriele Woelke,Sabine Brasche,Gert Strube,Joachim Heinrich,Peter Rzehak,Christa Meisinger,Gabriele Woelke,Sabine Brasche,Gert Strube,Joachim Heinrich,

OBJECTIVE: To investigate the effect of weight change and weight fluctuations on all-cause-mortality in men. METHODS: Within a prospective population-based cohort of 1,160 men aged 40-59 years at recruitment, complete weight change patterns from baseline and three follow-up examinations during a period of 15 years of follow-up was used to categorize the 505 men into stable obese, stable non-obese, weight gain, weight loss and weight fluctuation groups. For these men (age range: 55-74 years at start time of survival analysis) further survival was analyzed during the subsequent 15 years. RESULTS: Overall, 183 deaths were observed among the 505 men. Only weight fluctuations had a clear significant impact on all-cause mortality. Adjusted hazard rate ratio (HRR (95%-CI)) was 1.86 (1.31-2.66) after adjustment for age group, pre-existing cardiovascular disease or diabetes mellitus, smoking and socio-economic status. The risk rate due to weight loss was borderline significant (HRR = 1.81 (0.99-3.31)). Risk of death due to weight gain (HRR = 1.15 (0.70-1.88)) or stable obesity (HRR = 1.16 (0.69-1.94)), however, were not significantly increased compared to men staying non-obese for the first 15 years after cohort recruitment. CONCLUSION: Weight fluctuations are a major risk factor for all-cause mortality in middle aged men. Moreover, stable obesity does not increase further mortality in men aged 55-74 years in long-term follow-up.

Weight change, weight cycling and mortality in the ERFORT Male Cohort Study. Publishing Authors By Initials

P Rzehak,C Meisinger,G Woelke,S Brasche,G Strube,J Heinrich,P Rzehak,C Meisinger,G Woelke,S Brasche,G Strube,J Heinrich,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Weight change, weight cycling and mortality in the ERFORT Male Cohort Study. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: European journal of epidemiology

VOLUME: 22

Page Numbers: 665-73

Journal Abbreviation: Eur. J. Epidemiol.

ISSN: 0393-2990

DAY: 4

MONTH: 08

YEAR: 2007

Weight change, weight cycling and mortality in the ERFORT Male Cohort Study. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 8508062

Weight change, weight cycling and mortality in the ERFORT Male Cohort Study. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Weight change, weight cycling and mortality in the ERFORT Male Cohort Study. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Weight change, weight cycling and mortality in the ERFORT Male Cohort Study.

AFFILIATION: Institute of Epidemiology, GSF-National Research Center for Environment and Health, Ingolstaedter Landstrasse 1, 85764, Neuherberg, Germany. peter.rzehak@gsf.de

Country: Netherlands

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Eur J Epidemiol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Weight change, weight cycling and mortality in the ERFORT Male Cohort Study Related Publications

• A prospective study on the association between hay fever among children and incidence of asthma in East Germany.
• Allergic sensitization to cat in childhood as major predictor of incident respiratory allergy in young adults.
• Candles, dishwashers and Alzheimer's disease.
• Cycling power output produced during flat and mountain stages in the Giro d'Italia: a case study.
• Dare to share: a unique approach to presenting and publishing.
• Day care in relation to respiratory-tract and gastrointestinal infections in a German birth cohort study.
• Direct NMR analysis of cannabis water extracts and tinctures and semi-quantitative data on Delta(9)-THC and Delta(9)-THC-acid.
• Evaluation of a sampling strategy for estimation of long-term PM2.5 exposure for epidemiological studies.
• Expansion of signal transduction networks.
• FLT3 K663Q is a novel AML-associated oncogenic kinase: Determination of biochemical properties and sensitivity to Sunitinib (SU11248).
• Flory radius of polymers in a periodic field: An exact analytic theory.
• Hierarchy of metabolic compounds based on their synthesising capacity.
• High prevalence of pneumonia in children of a smelter town.
• Muscarinic excitation in grasshopper song control circuits is limited by acetylcholinesterase activity.
• Ménétrier disease and gastrointestinal stromal tumors: hyperproliferative disorders of the stomach.
• Power Output during the Tour de France.
• Ravens judge competitors through experience with play caching.
• Reviews of three books on medicinal plants from India.
• Second-order QCD corrections to the thrust distribution in electron-positron annihilation.
• Social factors, allergen, endotoxin, and dust mass in mattress.
• The stress of relocation and neuropeptides: an epidemiological study in children.
• Timing of Solid Food Introduction in Relation to Eczema, Asthma, Allergic Rhinitis, and Food and Inhalant Sensitization at the Age of 6 Years: Results From the Prospective Birth Cohort Study LISA.
• Weight change, weight cycling and mortality in the ERFORT Male Cohort Study.
• [BLOOD PRESSURE REGISTRATIONS AFTER MEDICATION WITH 1-P-CHLOROPHENYL-2,3-DIMETHYL-4-DIMETHYLAMINO-2-BUTANOL HCL.]
• [CONTINUOUS ELECTROCARDIOGRAPHIC RECORDINGS AFTER MEDICATION WITH 1-P-CHLOROPHENYL-2,3-DIMETHYL-4-DIMETHYLAMINO-2-BUTANOL HCL.]
• [Cardiotocography]
• [Counselling, treatment and aftercare of cancer patients by the family physician]
• [Not Available.]
• [Not Available.]
• [On the etiology and microbiology of actinomycosis. IV. On the sensitivity of Actinobacillus actinomycetem-comitans to the usual antibiotics and sulfonamides in vitro. (A contribution to the antibiotic therapy of actinomycosis in man)]